BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

853 related articles for article (PubMed ID: 31519198)

  • 1. Targeting T cell metabolism in the tumor microenvironment: an anti-cancer therapeutic strategy.
    Yin Z; Bai L; Li W; Zeng T; Tian H; Cui J
    J Exp Clin Cancer Res; 2019 Sep; 38(1):403. PubMed ID: 31519198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune-mediated anti-tumor effects of metformin; targeting metabolic reprogramming of T cells as a new possible mechanism for anti-cancer effects of metformin.
    Bahrambeigi S; Shafiei-Irannejad V
    Biochem Pharmacol; 2020 Apr; 174():113787. PubMed ID: 31884044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunometabolism: A new target for improving cancer immunotherapy.
    Guo C; Chen S; Liu W; Ma Y; Li J; Fisher PB; Fang X; Wang XY
    Adv Cancer Res; 2019; 143():195-253. PubMed ID: 31202359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting Metabolism in Cancer Cells and the Tumour Microenvironment for Cancer Therapy.
    Li J; Eu JQ; Kong LR; Wang L; Lim YC; Goh BC; Wong ALA
    Molecules; 2020 Oct; 25(20):. PubMed ID: 33092283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emerging role of metabolic reprogramming in tumor immune evasion and immunotherapy.
    Fan C; Zhang S; Gong Z; Li X; Xiang B; Deng H; Zhou M; Li G; Li Y; Xiong W; Zeng Z; Li X
    Sci China Life Sci; 2021 Apr; 64(4):534-547. PubMed ID: 32815067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting SLC1A5 and SLC3A2/SLC7A5 as a Potential Strategy to Strengthen Anti-Tumor Immunity in the Tumor Microenvironment.
    Nachef M; Ali AK; Almutairi SM; Lee SH
    Front Immunol; 2021; 12():624324. PubMed ID: 33953707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic Checkpoints: Novel Avenues for Immunotherapy of Cancer.
    Shevchenko I; Bazhin AV
    Front Immunol; 2018; 9():1816. PubMed ID: 30131808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-CCR5 Therapy Circumvents Immune Cell Exploitation by Tumors.
    Cancer Discov; 2016 Jun; 6(6):571. PubMed ID: 27125549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic reprogramming in the tumour microenvironment: a hallmark shared by cancer cells and T lymphocytes.
    Allison KE; Coomber BL; Bridle BW
    Immunology; 2017 Oct; 152(2):175-184. PubMed ID: 28621843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antitumor T-cell Reconditioning: Improving Metabolic Fitness for Optimal Cancer Immunotherapy.
    Rivadeneira DB; Delgoffe GM
    Clin Cancer Res; 2018 Jun; 24(11):2473-2481. PubMed ID: 29386217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted Therapy and Immunosuppression in the Tumor Microenvironment.
    Allegrezza MJ; Conejo-Garcia JR
    Trends Cancer; 2017 Jan; 3(1):19-27. PubMed ID: 28718424
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic Barriers to T Cell Function in Tumors.
    Sugiura A; Rathmell JC
    J Immunol; 2018 Jan; 200(2):400-407. PubMed ID: 29311381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting Adenosine in Cancer Immunotherapy to Enhance T-Cell Function.
    Vigano S; Alatzoglou D; Irving M; Ménétrier-Caux C; Caux C; Romero P; Coukos G
    Front Immunol; 2019; 10():925. PubMed ID: 31244820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reversing T-cell Dysfunction and Exhaustion in Cancer.
    Zarour HM
    Clin Cancer Res; 2016 Apr; 22(8):1856-64. PubMed ID: 27084739
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emerging concepts of T cell metabolism as a target of immunotherapy.
    Chang CH; Pearce EL
    Nat Immunol; 2016 Apr; 17(4):364-8. PubMed ID: 27002844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fundamentals of T Cell Metabolism and Strategies to Enhance Cancer Immunotherapy.
    Rangel Rivera GO; Knochelmann HM; Dwyer CJ; Smith AS; Wyatt MM; Rivera-Reyes AM; Thaxton JE; Paulos CM
    Front Immunol; 2021; 12():645242. PubMed ID: 33815400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T-cell immunometabolism against cancer.
    Jiang S; Yan W
    Cancer Lett; 2016 Nov; 382(2):255-258. PubMed ID: 27664755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic reprograming of anti-tumor immunity.
    Sukumar M; Kishton RJ; Restifo NP
    Curr Opin Immunol; 2017 Jun; 46():14-22. PubMed ID: 28412583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glycogen metabolism has a key role in the cancer microenvironment and provides new targets for cancer therapy.
    Zois CE; Harris AL
    J Mol Med (Berl); 2016 Feb; 94(2):137-54. PubMed ID: 26882899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TLR-mediated metabolic reprogramming in the tumor microenvironment: potential novel strategies for cancer immunotherapy.
    Huang L; Xu H; Peng G
    Cell Mol Immunol; 2018 May; 15(5):428-437. PubMed ID: 29553135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 43.